A comprehensive guide for healthcare professionals on managing hepatitis C in thalassemia patients, from epidemiology to treatment.
Introduction to the Book
Thalassemia patients face a significantly high prevalence of hepatitis C virus (HCV) infections. Recent advancements in their survival are attributed to better control of iron overload, safer blood transfusion practices, and improved management of complications. However, liver disease remains the leading cause of mortality among thalassemia patients worldwide.
Unfortunately, many thalassemia centers lack sufficient policies for controlling HCV infections. Managing thalassemia patients with HCV requires professional counseling and specialized diagnostic and therapeutic approaches. This book provides comprehensive guidance for health professionals on the epidemiology, screening, diagnosis, and treatment of HCV in this high-risk group, aiming to enhance HCV control among thalassemia patients globally, particularly in the Mediterranean region.
Chapters Overview
- Chapter 1: Virology (Page 7)
- Chapter 2: Epidemiology (Page 12)
- Chapter 3: Natural History (Page 26)
- Chapter 4: Diagnosis and Evaluation (Page 34)
- Chapter 5: Treatment (Page 42)
Book Details
- Author: Dr. Seyed-Moayed Alavian
- Publisher: Pouyan Kowsar Health Publishing Company; 1st Edition (April 8, 2022)
- Publication Date: April 8, 2022
- Print Length: 78 Pages
- Language: English
- ISBN: 978-622-99114-6-4
- Sponsored by: Salamat Pooyan
Links and Copyrights
- Amazon: Buy on Amazon
- Scinews: Read More on Scinews
- Official Website: Visit Brieflands
- PDF: Download Full-Text PDF
- Copyright: This book is published for personal use only under a Creative Commons Attribution Non-Commercial 4.0 License. For commercial use, please contact the publisher.
- Permission: For further permissions, contact the Publisher.
- Table of Contents: View in Persian